CHD Risk Score (Female)

Estimates a woman’s 10‑year risk of coronary heart disease events using traditional cardiovascular risk factors.

Age
30-34 yrs-935-39 yrs-440-44 yrs045-49 yrs+350-54 yrs+655-59 yrs+760-64 yrs+865-69 yrs+870-74 yrs+8
Total Cholesterol
Below 160 mg/dl-2160-199 mg/dl0200-239 mg/dl+1240-279 mg/dl+1Above 280 mg/dl+3
HDL-C
Above 60 mg/dl-350-59 mg/dl045-49 mg/dl+135-44 mg/dl+2Below 35 mg/dl+5
Blood Pressure
Below 120/Below 80 mmHg-3120-129/80-84 mmHg0130-139/85-89 mmHg0140-159/90-99 mmHg+2Above 160/Above 100 mmHg+3
Diabetes
No0Yes+4
Smoker
No0Yes+2

Indications for Use

Used for women without established cardiovascular disease to estimate 10‑year coronary heart disease risk and guide primary‑prevention decisions (lipid therapy, BP therapy) based on absolute risk. Derived from Framingham cohorts and validated in large, contemporary primary‑prevention samples, where age, BP, cholesterol, diabetes, and smoking remain core predictors 1 [Level I evidence]. Helps match treatment intensity to predicted absolute CHD risk and supports shared decision‑making.

Insights & Cautions

Start by interpreting estimates cautiously because most clinical risk equations overpredict CHD risk in contemporary women. In WHI external validation, Framingham-based models markedly overestimated 10‑year risk (eg, ATP‑III and Framingham CVD models) while the Reynolds model showed better calibration and discrimination (C‑statistic 0.765 vs 0.757; P=0.03) 1 [Level II evidence]. Scores may underperform in younger women and those with reproductive or inflammatory risk factors. Consider CAC when estimates are borderline.